Baxter
Trade Baxter 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BAX
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom.
BAX Key Statistics
Stock Snapshot
As of today, Baxter(BAX) shares are valued at $19.84. The company's market cap stands at 10.17B, with a P/E ratio of -11.79 and a dividend yield of 2.6%.
During the trading session on 2026-02-15, Baxter(BAX) shares reached a daily high of $20.13 and a low of $18.61. At a current price of $19.84, the stock is +6.6% higher than the low and still -1.4% under the high.
Trading activity shows a volume of 15.81M, compared to an average daily volume of 12.38M.
The stock's 52-week range extends from a low of $17.40 to a high of $37.74.
The stock's 52-week range extends from a low of $17.40 to a high of $37.74.
BAX News
Advertisement What the latest earnings mean for Baxter International (BAX) Baxter International (BAX) is back in focus after its fourth quarter 2025 update co...
Baxter International (NYSE:BAX) is rolling out a new decentralized operating model that removes a management layer to push more accountability to individual bus...
Baxter International Inc ((BAX)) has held its Q4 earnings call. Read on for the main highlights of the call. Valentine's Day Sale - 70% Off Unlock hedge fund-le...
Analyst ratings
71%
of 17 ratingsMore BAX News
Jefferies lowered the firm’s price target on Baxter (BAX) to $19 from $21 and keeps a Hold rating on the shares. Baxter reported Q4 sales of $2.97B, above conse...
...
Key Points Its final quarter of 2025 was mixed, with a notable whiff on earnings. On the plus side, it notched a convincing beat on revenue. 10 stocks we lik...
Baxter reported a fourth-quarter adjusted EPS of 44 cents, below the management guidance of 52-57 cents and the Wall Street estimate of 54 cents. The decrease w...
Image source: The Motley Fool. Feb. 12, 2026, 8:30 a.m. ET Call participants President & Chief Executive Officer — Andrew Hider Executive Vice President & Chie...
(RTTNews) - Health care company Baxter International, Inc. (BAX) reported Thursday a net loss attributable to shareholders for the fourth quarter of $1.12 billi...
Recently, Baxter International cut its quarterly dividend from US$0.17 per share to a token US$0.01, signaling a major shift in capital allocation and disappoin...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.